Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis

Journal of Experimental Medicine - Tập 205 Số 7 - Trang 1659-1672 - 2008
Xia Hong1, Deanna Diebold1, Richard Seonghun Nho1, D. Perlman1, Jill Kleidon1, Judy Kahm1, Svetlana Avdulov1, Mark S. Peterson1, John Nerva1, Peter B. Bitterman1, Craig A. Henke1
1Department of Medicine, University of Minnesota, Minneapolis, MN 55455

Tóm tắt

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive lung disease in which fibroblasts accumulate in the alveolar wall within a type I collagen–rich matrix. Although lung fibroblasts derived from patients with IPF display durable pathological alterations in proliferative function, the molecular mechanisms differentiating IPF fibroblasts from their normal counterparts remain unknown. Polymerized type I collagen normally inhibits fibroblast proliferation, providing a physiological mechanism to limit fibroproliferation after tissue injury. We demonstrate that β1 integrin interaction with polymerized collagen inhibits normal fibroblast proliferation by suppression of the phosphoinositide 3-kinase (PI3K)–Akt–S6K1 signal pathway due to maintenance of high phosphatase activity of the tumor suppressor phosphatase and tensin homologue (PTEN). In contrast, IPF fibroblasts eluded this restraint, displaying a pathological pattern of β1 integrin signaling in response to polymerized collagen that leads to aberrant activation of the PI3K–Akt–S6K1 signal pathway caused by inappropriately low PTEN activity. Mice deficient in PTEN showed a prolonged fibroproliferative response after tissue injury, and immunohistochemical analysis of IPF lung tissue demonstrates activation of Akt in cells within fibrotic foci. These results provide direct evidence for defective negative regulation of the proliferative pathway in IPF fibroblasts and support the theory that the pathogenesis of IPF involves an intrinsic fibroblast defect.

Từ khóa


Tài liệu tham khảo

2000, Am. J. Respir. Crit. Care Med., 161, 646, 10.1164/ajrccm.161.2.ats3-00

1991, Am. J. Pathol., 138, 1257

1986, Am. J. Pathol., 122, 443

1987, Am. J. Pathol., 126, 171

1989, Am. Rev. Respir. Dis., 140, 1693, 10.1164/ajrccm/140.6.1693

1995, J. Clin. Invest., 95, 1861, 10.1172/JCI117866

1995, Am. J. Physiol., 269, L819, 10.1152/ajpcell.1995.269.4.C819

1998, Am. J. Physiol., 275, L1192

2000, Am. J. Respir. Cell Mol. Biol., 22, 628, 10.1165/ajrcmb.22.5.3948

2001, Am. J. Respir. Cell Mol. Biol., 24, 591, 10.1165/ajrcmb.24.5.4333

2003, Am. J. Pathol., 163, 345, 10.1016/S0002-9440(10)63658-9

2005, Respir. Res., 6, 37, 10.1186/1465-9921-6-37

1980, J. Cell Sci., 41, 159, 10.1242/jcs.41.1.159

1988, J. Cell. Physiol., 137, 185, 10.1002/jcp.1041370123

1996, Cell., 87, 1069, 10.1016/S0092-8674(00)81801-2

1996, Tumour Biol., 17, 117, 10.1159/000217975

1997, EMBO J., 16, 2783, 10.1093/emboj/16.10.2783

2000, Mol. Biol. Cell., 11, 1973, 10.1091/mbc.11.6.1973

2004, J. Biol. Chem., 279, 31956, 10.1074/jbc.M401409200

2002, J. Biol. Chem., 277, 24667, 10.1074/jbc.M203565200

2004, J. Biol. Chem., 279, 33024, 10.1074/jbc.M313265200

2005, J. Biol. Chem., 280, 26630, 10.1074/jbc.M411798200

1998, Curr. Opin. Cell Biol., 10, 262, 10.1016/S0955-0674(98)80149-X

1998, Nature., 392, 730, 10.1038/33719

2002, J. Cell Biol., 158, 165, 10.1083/jcb.200112015

2003, Cancer Cell., 3, 483, 10.1016/S1535-6108(03)00088-6

2003, J. Biol. Chem., 278, 12384, 10.1074/jbc.M208544200

2000, J. Cell Sci., 113, 2375, 10.1242/jcs.113.13.2375

1996, J. Cell Biol., 132, 227, 10.1083/jcb.132.1.227

1998, J. Cell Sci., 111, 1117, 10.1242/jcs.111.8.1117

1995, J. Biol. Chem., 270, 17784, 10.1074/jbc.270.30.17784

2003, J. Biol. Chem., 278, 18671, 10.1074/jbc.M300879200

1999, J. Biol. Chem., 274, 20693, 10.1074/jbc.274.29.20693

2001, J. Cell Sci., 114, 2375, 10.1242/jcs.114.13.2375

2000, Mol. Cell. Biol., 20, 5010, 10.1128/MCB.20.14.5010-5018.2000

2001, J. Biol. Chem., 276, 993, 10.1074/jbc.M009134200

2004, Biochem. Soc. Trans., 32, 343, 10.1042/bst0320343

2004, Biochem. J., 382, 1, 10.1042/BJ20040825

1995, Am. J. Pathol., 146, 56

2003, J. Biol. Chem., 278, 40057, 10.1074/jbc.M303621200

2006, Am. J. Respir. Crit. Care Med., 173, 112, 10.1164/rccm.200507-1058OC

2008, Oncogene., 27, 1218, 10.1038/sj.onc.1210741

2005, Am. J. Pathol., 166, 1321, 10.1016/S0002-9440(10)62351-6

2006, Proc. Natl. Acad. Sci. USA., 103, 13180, 10.1073/pnas.0605669103

2002, Am. J. Respir. Crit. Care Med., 165, 277, 10.1164/ajrccm.165.2.ats01

1992, J. Clin. Invest., 90, 1778, 10.1172/JCI116052

2004, J. Biol. Chem., 279, 47589, 10.1074/jbc.M405497200

2004, Cancer Cell., 5, 553, 10.1016/j.ccr.2004.05.024